Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Flokind D 0.4mg/5mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Flokind D 0.4mg/5mg Tablet is a combination of two medicines: Tamsulosin and Dutasteride which relieve the symptoms of benign prostatic hyperplasia. Tamsulosin is an alpha-blocker. It works by relaxing muscle around the bladder exit and prostate gland so urine is passed more easily. Dutasteride is a 5-alpha-reductase inhibitor which helps in shrinking the prostate by decreasing the level of a hormone that causes the prostate to grow.
Taking tamsulosin with alcohol may lower your blood pressure. This can cause dizziness or feeling like you might pass out, especially when getting up from a sitting or lying position.
Flokind D 0.4mg/5mg Tablet is highly unsafe to use during pregnancy. Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.
No information is available on the use of Flokind D 0.4mg/5mg Tablet during lactation. Please consult your doctor.
Flokind D 0.4mg/5mg Tablet does not usually affect your ability to drive.
Flokind D 0.4mg/5mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Flokind D 0.4mg/5mg Tablet may not be needed in these patients. Please consult your doctor.
Flokind D 0.4mg/5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Flokind D 0.4mg/5mg Tablet may be needed. Please consult your doctor. Use of Flokind D 0.4mg/5mg Tablet is not recommended in patients with severe liver disease.
“The following are the results of on-going survey on 1mg.com for Flokind D 0.4mg/5mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 8th Mar 2017.